Copeptin in Hemodialysis Patients with Left Ventricular Dysfunction.
10.3349/ymj.2015.56.4.976
- Author:
Jae Seok KIM
1
;
Jae Won YANG
;
Moon Hee CHAI
;
Jun Young LEE
;
Hyeoncheol PARK
;
Youngsub KIM
;
Seung Ok CHOI
;
Byoung Geun HAN
Author Information
1. Division of Nephrology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea. neptune@yonsei.ac.kr
- Publication Type:Original Article
- Keywords:
Copeptin;
hemodialysis;
ventricular dysfunction
- MeSH:
Adult;
Aged;
Biomarkers/blood;
Echocardiography;
Female;
Glycopeptides/*blood;
Humans;
Kidney Failure, Chronic/*blood/complications/therapy;
Male;
Middle Aged;
Natriuretic Peptide, Brain/blood;
Predictive Value of Tests;
Prognosis;
ROC Curve;
Renal Dialysis/*adverse effects;
Sensitivity and Specificity;
Ventricular Dysfunction, Left/*blood/complications/*physiopathology
- From:Yonsei Medical Journal
2015;56(4):976-980
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Copeptin has been considered as a useful marker for diagnosis and prediction of prognosis in heart diseases. However, copeptin has not been investigated sufficiently in hemodialysis patients. This study aimed to investigate the general features of copeptin in hemodialysis and to examine the usefulness of copeptin in hemodialysis patients with left ventricular dysfunction (LV dysfunction). MATERIALS AND METHODS: This study included 41 patients on regular hemodialysis. Routine laboratory data and peptides such as the N-terminal of the prohormone brain natriuretic peptide and copeptin were measured on the day of hemodialysis. Body fluid volume was estimated by bioimpedance spectroscopy, and the E/Ea ratio was estimated by echocardiography. RESULTS: Copeptin increased to 171.4 pg/mL before hemodialysis. The copeptin had a positive correlation with pre-dialysis body fluid volume (r=0.314; p=0.04). The copeptin level decreased along with body fluid volume and plasma osmolality during hemodialysis. The copeptin increased in the patients with LV dysfunction more than in those with normal LV function (218.7 pg/mL vs. 77.6 pg/mL; p=0.01). Receiver operating characteristic curve analysis showed that copeptin had a diagnostic value in the hemodialysis patients with LV dysfunction (area under curve 0.737; p=0.02) and that the cut-off value was 125.48 pg/mL (sensitivity 0.7, specificity 0.8, positive predictive value 0.9, negative predictive value 0.6). CONCLUSION: Copeptin increases in hemodialysis patients and is higher in patients with LV dysfunction. We believe that copeptin can be a useful marker for the diagnosis of LV dysfunction in hemodialysis patients.
